These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1839632)

  • 1. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Baldwin D; Bullock T; Montgomery D; Montgomery S
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
    Mann JJ; Kapur S
    Arch Gen Psychiatry; 1991 Nov; 48(11):1027-33. PubMed ID: 1747018
    [No Abstract]   [Full Text] [Related]  

  • 3. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant drugs and the emergence of suicidal tendencies.
    Teicher MH; Glod CA; Cole JO
    Drug Saf; 1993 Mar; 8(3):186-212. PubMed ID: 8452661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicide and antidepressants.
    Montgomery SA
    Drugs; 1992; 43 Suppl 2():24-30; discussion 30-1. PubMed ID: 1378370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical overview of serotonin reuptake inhibitors.
    Rickels K; Schweizer E
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does treatment with antidepressant medication increase suicidal behavior?
    Goldblatt MJ; Schatzberg AF
    Int Clin Psychopharmacol; 1991; 6(4):219-26. PubMed ID: 1816279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvoxamine: an antidepressant for the elderly?
    Kellett JM
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):26-9. PubMed ID: 1931933
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of paroxetine.
    Boyer WF; Feighner JP
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants and suicide risk: issues of chemical and behavioral toxicity.
    Molcho A; Stanley M
    J Clin Psychopharmacol; 1992 Apr; 12(2 Suppl):13S-18S. PubMed ID: 1577985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports.
    Sharma T; Guski LS; Freund N; Gøtzsche PC
    BMJ; 2016 Jan; 352():i65. PubMed ID: 26819231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
    Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
    Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants and suicidal risk.
    Müller-Oerlinghausen B; Berghöfer A
    J Clin Psychiatry; 1999; 60 Suppl 2():94-9; discussion 111-6. PubMed ID: 10073395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.